This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Correction

This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

doi:10.4088/JCP.13lcx08958).

Correction

In the article "Continuation of Quetiapine Versus Switching to Placebo or Lithium for Maintenance Treatment of Bipolar I Disorder (Trial 144: A Randomized Controlled Study)" by Richard H. Weisler, MD, and colleagues in the November 2011 issue (J Clin Psychiatry 2011;72[11]:1452-1464), in Figure 2 on page 1456, the number of patients randomized to quetiapine who discontinued due to mood event should be n = 87.

The staff regret the error. The online article at PSYCHIATRIST.COM has been corrected.

Volume: 75

Quick Links: Bipolar Disorder